![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » INDIA'S LUPIN, TORRENT AMONG BIDDERS FOR 47.5 PCT OF POLAND'S JELFA
INDIA'S LUPIN, TORRENT AMONG BIDDERS FOR 47.5 PCT OF POLAND'S JELFA
August 19, 2005
Lupin Laboratories Ltd and Torrent Pharmaceuticals have put in separate bids for the Polish government's 47.5 pct stake in drug major Jelfa Pharmaceutical, Business Standard reported. The two Indian companies are among six bidders eyeing the Polish government's stake in Jelfa, it said, adding that the bidding process is expected to be completed next month. Jelfa is one of the largest pharmaceutical firms in Poland and manufactures hormonal and cardiological drugs and multivitamin preparations.
Forbes (http://www.forbes.com/markets/feeds/afx/2005/08/17/afx2184283.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct